---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-037162"
form_type: "8-K"
ticker: "RBOT"
cik: "0001812173"
company_name: "Vicarious Surgical Inc."
filed_at: "2024-04-29T23:59:59+00:00"
generated_at: "2026-06-03T05:41:58.614459+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vicarious Surgical reports Q1 2024 net loss of $17.0M; cash burn guidance unchanged at $50M

## Summary
- GAAP net loss $17.0M ($0.10/sh) vs $26.9M ($0.21) YoY; adjusted net loss $15.1M ($0.09).
- Operating expenses fell 28% to $16.1M from $22.3M; R&D $10.0M, G&A $5.0M, S&M $1.1M.
- Cash & investments $84.1M; Q1 cash burn $14.1M; FY 2024 cash burn guidance reaffirmed at ~$50M.
- Completed spring cadaver lab; refining V1.0 system ahead of final integration in fall 2024.

## SEC filing metadata
- accession: 0001213900-24-037162
- form_type: 8-K
- ticker: RBOT
- cik: 0001812173
- company_name: Vicarious Surgical Inc.
- filed_at: 2024-04-29T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812173/000121390024037162/0001213900-24-037162-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812173/000121390024037162/ea0204772-8k_vicarious.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-037162
- JSON: https://secwatch.observer/filing/0001213900-24-037162.json
- Plain text: https://secwatch.observer/filing/0001213900-24-037162.txt

## Key facts
- Earnings Releases
  Vicarious Surgical Inc. reported the quarter ended March 31, 2024 results: net income GAAP net loss for the first quarter was $17.0 million, equating to a net loss per share of $0.10, EPS $0.10. Guidance reaffirmed.
  - Period: the quarter ended March 31, 2024
  - Net income: GAAP net loss for the first quarter was $17.0 million, equating to a net loss per share of $0.10
  - EPS: $0.10
  - Guidance: reaffirmed
  - Result: reported results
  source text: Vicarious Surgical Reports First Quarter 2024 Financial Results
  evidence_url: https://www.sec.gov/Archives/edgar/data/1812173/000121390024037162/0001213900-24-037162-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.